A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression.

Abstract
We examined the efficacy and safety of three different dosages of venlafaxine hydrochloride (75, 225, and 375 mg/day) in a multicenter, randomized, double-blind, placebo-controlled, four-group study.

This publication has 0 references indexed in Scilit: